Fulltext

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]

Machiela MJ 1 , Hofmann JN 1 , Carreras-Torres R 2 , Brown KM 1 , Johansson M 2 , Wang Z 3 Show all authors , Foll M 2 , Li P 2 , Rothman N 1 , Savage SA 1 , Gaborieau V 2 , McKay JD 2 , Ye Y 4 , Henrion M 5 , Bruinsma F 6 , Jordan S 7 , Severi G 8 , Hveem K 9 , Vatten LJ 10 , Fletcher T 11 , Koppova K 12 , Larsson SC 13 , Wolk A 13 , Banks RE 14 , Selby PJ 14 , Easton DF 15 , Pharoah P 15 , Andreotti G 1 , Freeman LEB 1 , Koutros S 1 , Albanes D 1 , Mannisto S 16 , Weinstein S 1 , Clark PE 17 , Edwards TE 17 , Lipworth L 17 , Gapstur SM 18 , Stevens VL 18 , Carol H 19 , Freedman ML 19 , Pomerantz MM 19 , Cho E 20 , Kraft P 21 , Preston MA 22 , Wilson KM 21 , Gaziano JM 23 , Sesso HS 21 , Black A 1 , Freedman ND 1 , Huang WY 1 , Anema JG 24 , Kahnoski RJ 24 , Lane BR 25 , Noyes SL 26 , Petillo D 26 , Colli LM 1 , Sampson JN 1 , Besse C 27 , Blanche H 28 , Boland A 27 , Burdette L 1 , Prokhortchouk E 29 , Skryabin KG 29 , Yeager M 1 , Mijuskovic M 30 , Ognjanovic M 31 , Foretova L 32 , Holcatova I 33 , Janout V 34 , Mates D 35 , Mukeriya A 36 , Rascu S 37 , Zaridze D 36 , Bencko V 38 , Cybulski C 39 , Fabianova E 12 , Jinga V 37 , Lissowska J 40 , Lubinski J 39 , Navratilova M 32 , Rudnai P 41 , Szeszenia-Dabrowska N 42 , Benhamou S 43 , Cancel-Tassin G 44 , Cussenot O 45 , Bueno-de-Mesquita HBA 46 , Canzian F 47 , Duell EJ 48 , Ljungberg B 49 , Sitaram RT 49 , Peters U 50 , White E 50 , Anderson GL 50 , Johnson L 50 , Luo J 51 , Buring J 21 , Lee IM 52 , Chow WH 4 , Moore LE 1 , Wood C 53 , Eisen T 54 , Larkin J 55 , Choueiri TK 19 , Lathrop GM 56 , Teh BT 26 , Deleuze JF 57 , Wu X 4 , Houlston RS 58 , Brennan P 2 , Chanock SJ 1 , Scelo G 2 , Purdue MP 59

Affiliations 

  • 1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA
  • 2 International Agency for Research on Cancer (IARC), Lyon, France
  • 3 St. Jude Children's Research Hospital, Memphis, TN, USA
  • 4 Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • 5 Icahn School of Medicine, New York, NY, USA
  • 6 Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia
  • 7 QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; School of Public Health, The University of Queensland, Brisbane, Australia
  • 8 Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia; Human Genetics Foundation (HuGeF), Torino, Italy; Centre de Recherche en Épidémiologie et Santé des Populations, Université Paris-Saclay, UPS, USQ, Gustave Roussy, Villejuif, France
  • 9 HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Sweden
  • 10 Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
  • 11 London School of Hygiene and Tropical Medicine, University of London, London, UK
  • 12 Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia
  • 13 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  • 14 Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK
  • 15 Department of Oncology, and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
  • 16 National Institute for Health and Welfare, Helsinki, Finland
  • 17 Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
  • 18 American Cancer Society, Atlanta, GA, USA
  • 19 Dana-Farber Cancer Institute, Boston, MA, USA
  • 20 Brown University, Providence, RI, USA
  • 21 Harvard T.H. Chan School of Public Health, Boston, MA, USA
  • 22 Brigham and Women's Hospital, Boston, MA, USA
  • 23 Brigham and Women's Hospital, Boston, MA, USA; Veterans Administration, Boston, MA, USA
  • 24 Division of Urology, Spectrum Health, Grand Rapids, MI, USA
  • 25 Division of Urology, Spectrum Health, Grand Rapids, MI, USA; College of Human Medicine, Michigan State University, Grand Rapids, MI, USA
  • 26 Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA
  • 27 Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France
  • 28 Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France
  • 29 Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation; Kurchatov Scientific Center, Moscow, Russian Federation
  • 30 Clinic for Nephrology, Military Medical Academy, Belgrade, Serbia
  • 31 International Organization for Cancer Prevention and Research (IOCPR), Belgrade, Serbia
  • 32 Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic
  • 33 Second Faculty of Medicine, Institute of Public Health and Preventive Medicine, Charles University, Prague, Czech Republic
  • 34 Department of Preventive Medicine, Faculty of Medicine, Palacky University, Czech Republic
  • 35 National Institute of Public Health, Bucharest, Romania
  • 36 Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation
  • 37 Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania
  • 38 First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic
  • 39 International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
  • 40 The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland
  • 41 National Public Health Center, National Directorate of Environmental Health, Budapest, Hungary
  • 42 Department of Epidemiology, Institute of Occupational Medicine, Lodz, Poland
  • 43 INSERM U946, Paris, France; CNRS UMR8200, Institute Gustave Roussy, Villejuif, France
  • 44 CeRePP, Paris, France; UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Paris, France
  • 45 CeRePP, Paris, France; UPMC Univ Paris 06, Institut Universitaire de Cancérologie, Paris, France; AP-HP, Department of Urology, Hopitaux Universitaires Est Parisien Tenon, Paris, France
  • 46 Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, UK; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Pantai Valley, Kuala Lumpur, Malaysia
  • 47 Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • 48 Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain
  • 49 Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden
  • 50 Fred Hutchinson Cancer Research Center, Seattle, WA, USA
  • 51 Department of Epidemiology and Biostatistics, School of Public Health Indiana University Bloomington, Bloomington, IN, USA
  • 52 Harvard T.H. Chan School of Public Health, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA
  • 53 Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • 54 University of Cambridge, Cambridge, UK
  • 55 Royal Marsden NHS Foundation Trust, London, UK
  • 56 McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada
  • 57 Centre National de Recherche en Genomique Humaine (CNRGH), Institut de biologie François Jacob, Commissariat à l'Energie Atomique et aux Energies Alternatives, Evry, France; Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France
  • 58 The Institute of Cancer Research, London, UK
  • 59 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA. Electronic address: purduem@mail.nih.gov
Eur Urol, 2018 Sep;74(3):e85-e86.
PMID: 29853305 DOI: 10.1016/j.eururo.2018.05.017

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications